The findings, which were part of a larger review commissioned by the World Health Organisation, suggested there was "no ...
The findings show no evidence to suggest that hormone replacement therapy (HRT) either increases or decreases dementia risk ...
Many doctors agree with the Food and Drug Administration’s recent decision to remove the black box warnings on at least some ...
New study reveals effects of HRT on dementia risk - Research has been done to look into potential links between HRT and the ...
Hormone replacement therapy, or HRT, was the first menopause treatment available to women, approved by the FDA in 1941. It ...
Women who use hormone replacement therapy (HRT) for at least a decade before their final period may see a reduced risk of breast cancer, heart attacks, or strokes, according to a new analysis.
Hormone replacement therapy (HRT) has been linked to an increase in heart disease and blood clots in a study. The number of women using the treatment in England has surged to about 2.6 million. It ...
Menopause represents a profound systemic shift involving cardiovascular, skeletal, and neurological health, requiring ...
Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...
HRT does not increase breast cancer risk in BRCA1/BRCA2 variant carriers, with lower incidence in users versus non-users. Estrogen-alone therapy is linked to reduced mortality, while estrogen plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results